Cagrilintide Cagrilintide is a synthetic peptide under investigation in preclinical and early clinical studies for its potential therapeutic effects related to gastrointestinal and metabolic health
Non-coding variants are indicated with + symbols
In TMV-infected, resistant tobacco most of the SA is conjugated (bound) to glucose as SAG, SGE and MeSAG ( We demonstrated that OTC treatments induce in planta SA accumulation in tobacco, which implies that OTC induces plant defense responses to a similar extent as SA
[DOI] [PMC free article] [PubMed] [Google Scholar] 87.Jelinek L.J., Lok S., Rosenberg G.B., Smith R.A., Grant F.J., Biggs S., Bensch P.A., Kuijper J.L., Sheppard P., Sprecher C.A., et al